NEW YORK (GenomeWeb News) – UK-based Asterand today said that it will acquire BioSeek, a developer of cell-based assay systems, in a deal worth up to $14 million.

Asterand, which provides tissue-based services for drug discovery, said that the acquisition will provide it with highly complementary technologies, specifically BioSeek's BioMap platform and human cell-based assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."